Role of PLCγ1 in the modulation of cell migration and cell invasion in glioblastoma.


Journal

Advances in biological regulation
ISSN: 2212-4934
Titre abrégé: Adv Biol Regul
Pays: England
ID NLM: 101572336

Informations de publication

Date de publication:
01 2022
Historique:
received: 02 11 2021
revised: 12 11 2021
accepted: 16 11 2021
pubmed: 26 11 2021
medline: 6 4 2022
entrez: 25 11 2021
Statut: ppublish

Résumé

Phosphoinositide-specific phospholipases C (PLCs) are a class of enzymes involved in several cell activities, such as cell cycle regulation, proliferation, differentiation and cytoskeletal dynamics. Among these enzymes, PLCγ1 is one of the most expressed PLCs in the brain, contributing to a complex network in the developing nervous system. Several studies have shown that PLCγ1 signaling imbalance is linked to several brain disorders, including glioblastoma, the most aggressive brain tumor in adults. Indeed, it has been demonstrated a link between PLCγ1 inhibition and the arrest of glioma cell motility of fetal rat brain aggregates and the impairment of cell invasion abilities following its down-regulation. This study aims to determine the pathological influence of PLCγ1 in glioblastoma, through a translational study which combines in silico data, data from glioblastoma patients' samples and data on engineered cell lines. We found out that PLCγ1 gene expression correlates with the pathological grade of gliomas, and it is higher in fifty patients' glioblastoma tissue samples compared to twenty healthy controls. Moreover, it was demonstrated that PLCγ1 silencing in U87-MG leads to a reduction in cell migration and invasion abilities. The opposite trend was observed following PLCγ1 overexpression, suggesting an interesting possible involvement of PLCγ1 in gliomas' aggressiveness.

Identifiants

pubmed: 34819252
pii: S2212-4926(21)00054-3
doi: 10.1016/j.jbior.2021.100838
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100838

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Maria Vittoria Marvi (MV)

Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.

Sara Mongiorgi (S)

Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.

Giulia Ramazzotti (G)

Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.

Matilde Y Follo (MY)

Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.

Anna Maria Billi (AM)

Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.

Matteo Zoli (M)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; Pituitary Unit, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Diego Mazzatenta (D)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; Pituitary Unit, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Luca Morandi (L)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; Functional and Molecular Neuroimaging Unit, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Sofia Asioli (S)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; Pituitary Unit, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Anatomic Pathology Unit, Azienda USL di Bologna, Bologna, Italy.

Veronica Papa (V)

Department of Motor Sciences and Wellness (DiSMeB), Università Degli Studi di Napoli "Parthenope,", 80133, Napoli, Italy.

James A McCubrey (JA)

Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC, USA.

Pann-Ghill Suh (PG)

Korea Brain Research Institute, Daegu, 41062, South Korea; School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 689-798, South Korea.

Lucia Manzoli (L)

Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.

Lucio Cocco (L)

Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.

Stefano Ratti (S)

Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy. Electronic address: stefano.ratti@unibo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH